For instance, treatment of lung cancer cells with anti-ENO1 monoclonal antibodies in vitro suppressed cell-associated plasminogen and matrix metalloproteinase activation, collagen and gelatin degradation, and cell invasion (Hsiao et al., 2013). This evidence concerns the gene ENO1 and lung cancer.